Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science. Issue 10 (12th July 2022)

• Record Type: Journal Article
• Authors: Inamura, Kentaro; Hamada, Tsuyoshi; Bullman, Susan; Ugai, Tomotaka; Yachida, Shinichi; Ogino, Shuji
• Is Part Of: Gut. Volume 71:Issue 10(2022)
• Page Start: 2107
• Page End: 2122
• Publication Date: 2022-07-12
• Subjects: CANCER EPIDEMIOLOGY -- CANCER IMMUNOBIOLOGY -- CANCER PREVENTION -- INTESTINAL MICROBIOLOGY -- MOLECULAR PATHOLOGY; Gastroenterology -- Periodicals; 616.33
• DOI: 10.1136/gutjnl-2022-327209
• Languages: English
• ISSNs: 0017-5749

Abstract

Abstract : Cancer is generally regarded as a localised disease, with the well-established role of the tumour microenvironment. However, the realm of cancer goes beyond the tumour microenvironment, and cancer should also be regarded as a systemic and environmental disease. The exposome ( ie, the totality of exposures), which encompasses diets, supplements, smoking, alcohol, other lifestyle factors, medications, etc, likely alters the microbiome (inclusive of bacteria, viruses, archaea, fungi, parasites, etc ) and immune system in various body sites and influences tumour phenotypes. The systemic metabolic/inflammatory status, which is likely influenced by exposures and intestinal physiological changes, may affect tissue microenvironment of colorectum and any other organs. Germline genomic factors can modify disease phenotypes via gene-by-environment interactions. Although challenges exist, it is crucial to advance not only basic experimental research that can analyse the effects of exposures, microorganisms and microenvironmental components on tumour evolution but also interdisciplinary human population research that can dissect the complex pathogenic roles of the exposome, microbiome and immunome. Metagenomic, metatranscriptomic and metabolomic analyses should be integrated into well-designed population research combined with advanced methodologies of artificial intelligence and molecular pathological epidemiology. Ideally, a prospective cohort study design that enables biospecimen (such as stool) collection before disease detection should be considered to address reverse causation and recall biases. Robust experimental and observational research together can provide insights into dynamic interactions between environmental exposures, microbiota, tumour and immunity during carcinogenesis processes, thereby helping us develop precision prevention and therapeutic strategies to ultimately reduce the cancer burden.